1 / 3

Capillary and Venous Blood Sampling Devices Market

u201cCapillary and Venous Blood Sampling Devices Market: Global Demand Analysis & Opportunity Outlook 2035u201d delivers a detailed competitoru2019s analysis and a detailed overview of the global capillary and venous blood sampling devices market

meghanester
Download Presentation

Capillary and Venous Blood Sampling Devices Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Capillary and Venous Blood Sampling Devices Market 2023 Size, Share, Growth with a CAGR of 7.2% | Revenue, Business Strategies 2035 Research Nester’s recent market research analysis on “Capillary and Venous Blood Sampling Devices Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitor’s analysis and a detailed overview of the global capillary and venous blood sampling devices market in terms of market segmentation by product, device, application, end-user, and by region. Increasing Prevalence of Diabetes Worldwide to Drive Growth of Global Capillary and Venous Blood Sampling Devices Market The increasing prevalence of diabetes is expected to have a positive impact on the market for capillary and venous blood sampling devices. Population with diabetes must monitor their blood sugar levels regularly to manage their condition and prevent complications. For instance, as per the WHO statistics, a total of 537 million individuals (20-79 years old) worldwide have diabetes. It is anticipated that by 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. Adults with diabetes make up three out of four of the population in low- and middle-income nations. Capillary and venous blood sampling equipment are extensively used in hospitals, clinics, and other healthcare settings for blood collection. These technologies enable healthcare providers to rapidly and efficiently collect blood samples, lowering the risk of complications and ensuring the safety and accuracy of the blood samples. Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4965 Some of the major growth factors and challenges that are associated with the growth of the global capillary and venous blood sampling devices market are: Growth Drivers: •Rise in demand for blood collection and transfusions •Increasing demand for apheresis Challenges:

  2. Stringent regulatory approval and product recall associated with capillary and venous blood sampling devices, and limited access to healthcare in low and middle-income countries are some of the major factors anticipated to hamper the growth of the global capillary and venous blood sampling devices market. By product, the global capillary and venous blood sampling devices market is segmented into capillary blood collection devices and venous blood collection devices. The venous blood collection devices segment is to garner the highest CAGR of 7.6% over the forecast period. This can be attributed due to the rising preference in clinical laboratories for the detection of major chronic diseases as no repeated blood collection process is required. Venous blood collection is the procedure often done in routine laboratory tests due to the benefits of these venous blood collection devices as they offer the exact filling volume. It has fueled the growth of capillary and venous blood sampling devices over the forthcoming years. Moreover, the main venous blood sampling devices are tubes and vacutainer systems used for cancer, HIV/AIDS and other blood testing which are fueling the expansion of the venous blood collection devices market. Request for customization @https://www.researchnester.com/customized-reports-4965 By region, the North American capillary and venous blood sampling devices market are to generate the highest revenue of USD 5,040.2 million by the end of 2035. The demand for capillary and venous blood sample devices is increasing along with the surging number of people suffering from communicable and non-communicable diseases. For instance, heart disease is the main cause of death for both sexes and the majority of American populations. Demand for blood testing for these illnesses will increase since almost 20% of all fatalities from coronary artery disease in 2020 will be in persons under the age of 65. Obtain this Report @ https://www.researchnester.com/reports/capillary-and-venous-blood- sampling-devices-market/4965 This report also provides the existing competitive scenario of some of the key players of the global capillary and venous blood sampling devices market which include company profiling of Abacus ALS, Medtronic, Bio-Rad Laboratories, Inc., B. Braun Melsungen AG, Thermo Fisher Scientific, Inc., Medtronic Plc, Merck KGaA, Bio-Rad Laboratories, Inc., Ypsomed Holding AG,

  3. Owen Mumford Ltd., Greiner Bio-One International GmbH, SB-KAWASUMI LABORATORIES, INC., Terumo Corporation and others. About Us Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion, and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919

More Related